Equity Analysis

Quarterly Results

    Aspira Pathlab & Diagnostics Ltd
    Industry :  Healthcare
    BSE Code
    ISIN Demat
    Book Value()
    540788
    INE500C01017
    5.0650928
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    65.27
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales6.184.643.82
Other Operating Income0.000.000.00
Other Income 0.080.090.08
Total Income6.254.733.89
Total Expenditure 4.824.293.94
PBIDT1.430.44-0.04
Interest 0.080.080.08
PBDT1.350.36-0.13
Depreciation0.360.380.38
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax0.99-0.02-0.50
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.99-0.02-0.50
EPS (Unit Curr.)0.96-0.02-0.49
EPS (Adj) (Unit Curr.)0.96-0.02-0.49
Calculated EPS (Unit Curr.)0.96-0.02-0.49
Calculated EPS (Adj) (Unit Curr.)0.96-0.02-0.49
Calculated EPS (Ann.) (Unit Curr.)3.85-0.06-1.95
Calculated EPS (Adj) (Ann.) (Unit Curr.)3.85-0.06-1.95
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.2910.2910.29
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)23.149.48-1.05
PBDTM(%)21.847.76-3.40
PATM(%)16.02-0.43-13.09
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.96-0.02-0.49